NASDAQ$CBUS
Cibus Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Calyxt reported an increase in revenue driven by grain sales, but gross margin was negative due to changes in go-to-market strategy and commodity derivative losses. The company also reported a decrease in operating expenses and a net loss.
Calyxt's Q4 2020 revenue increased significantly due to grain sales and liquidation of inventories. However, the gross margin was negative. Operating expenses decreased, and the company secured $14.0 million in proceeds from a capital raise.
- Revenue increased by 270% to $13.9 million due to grain sales and inventory liquidation.
- Gross margin was negative $4.9 million, impacted by go-to-market strategy changes and commodity derivative losses.
- Operating expenses decreased by 22% to $8.1 million due to the change in go-to-market strategy.
- Net loss increased to $13.4 million, driven by the increase in negative gross margin partially offset by the decline in operating expenses.
Headline financials
Revenue & EPS history
Cibus · Revenue · Quarterly
$13.9M
Forward guidance
Calyxt is focusing on technology licensing, product development, and seed sales arrangements and expects to see continued progress in development of winter oats and hemp.
Tailwinds
- Continued development of winter oat projects targeting food, feed, and cover crop markets.
- Continued development of hemp projects targeting protein, nutraceutical, fiber, and advanced materials markets.
- Secured commitment from ADM to purchase remaining 2019 grain inventory and all 2020 grain production.
- Executed commercial agreement with S&W Seed Company on IQ™ Alfalfa product, marking Calyxt’s first trait license agreement.
- Entered into an agreement with Perdue AgriBusiness for the sale of soybean seed in 2021.
Headwinds
- The development of winter oat projects is not expected to become available for commercialization until 2026.
- The development of hemp projects is not expected to become available for commercialization until 2024.
- Gross margin was negative $4.9 million, or a negative 35 percent, in the fourth quarter of 2020.
- Net loss was $13.4 million in the fourth quarter of 2020.
- Calyxt is undertaking a search for a new CEO to replace Jim Blome.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2020
-1.1%
Avg return
Earnings day
-2.2%
Avg return
5 days after
-12.5%
Avg return
30 days after
37%
13 / 35 earnings
Positive
+23.6%
Q4 2019
Best reaction
-25.1%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.8% | -10.3% | -15.2% | |
| Q4 2025 | -16.7% | -24.7% | -56.8% | |
| Q3 2025 | -0.8% | +1.6% | +28.8% | |
| Q2 2025 | -3.5% | -11.6% | -7.5% | |
| Q1 2025 | -7.8% | -8.1% | -29.4% | |
| Q4 2024 | -6.4% | -9.6% | -23.7% | |
| Q3 2024 | +14.5% | +15.2% | -8.9% | |
| Q2 2024 | -9.2% | +2.7% | -42.4% | |
| Q1 2024 | +2.2% | +9.5% | -37.5% | |
| Q4 2023 | -0.7% | +2.2% | +7.4% | |
| Q3 2023 | +17.0% | +5.0% | -8.8% | |
| Q2 2023 | -9.7% | -13.8% | -19.8% | |
| Q1 2023 | -3.6% | -8.3% | -15.8% | |
| Q4 2022 | +1.6% | -0.7% | -21.5% | |
| Q3 2022 | -1.4% | -7.7% | +22.5% | |
| Q2 2022 | +12.4% | +4.3% | -11.6% | |
| Q1 2022 | -17.3% | -27.4% | -60.0% | |
| Q4 2021 | -2.8% | -21.3% | -20.6% | |
| Q3 2021 | -7.4% | -9.0% | -41.9% | |
| Q2 2021 | +12.0% | +15.1% | +19.9% | |
| Q1 2021 | +4.6% | +3.3% | -17.4% | |
| Q4 2020 | -25.1% | -24.7% | -35.6% | |
| Q3 2020 | -1.4% | -4.0% | -44.3% | |
| Q2 2020 | -6.6% | +0.2% | -8.3% | |
| Q1 2020 | -15.0% | -9.4% | +27.9% | |
| Q4 2019 | +23.6% | +22.7% | -10.1% | |
| Q3 2019 | -9.7% | -10.2% | -16.3% | |
| Q2 2019 | +2.7% | -13.1% | -23.9% | |
| Q1 2019 | -3.5% | -6.7% | -9.3% | |
| Q4 2018 | +8.3% | +20.0% | +34.0% | |
| Q3 2018 | -2.9% | -4.9% | -22.1% | |
| Q2 2018 | -0.7% | -3.1% | -10.8% | |
| Q1 2018 | +1.9% | +22.1% | +28.1% | |
| Q4 2017 | +6.4% | +18.8% | +16.9% | |
| Q3 2017 | +7.8% | +8.2% | -2.2% | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro